CLEANANCE COMEDOMED : THE ANTI-BLEMISH CONCENTRATE TO (FINALLY) GET RID OF PIMPLES.
A unique process: an active ingredient that acts directly at the root of the pimple, to make it disappear on the surface, permanently.
Discover the secrets of our anti-blemish hero.
Playing YouTube videos requires the use of cookies in order to offer you targeted advertising based on your browsing For more information, please visit YouTube's « cookie » policy.
You have rejected Youtube's cookies and therefore you cannot view the video.
You can change your choices by clicking on « Cookie Settings » and accept Youtube's cookies to enable the video.
You can change this setting and withdraw your consent at any time.
A treatment developed with dermatologists
Our Anti-blemish concentrate was co-developed with Professor Saurat, an internationally renowned dermatologist and acne specialist.
Today, our care is prescribed by dermatologists worldwide1.
A pimple on the face is a microcomedo in the deeper layers of the skin. As long as it's not thoroughly removed, the blemish returns. That's why you wonder why your pimples persist, even as an adult.
Cleanance Comedomed global acne solution contains ComedoclastinTM. This plant extract, derived from milk thistle seeds, acts on the invisible part of the pimple (microcomedo), making it disappear permanently from the surface.
Cleanance Comedomed : the expert ally of acne-prone skin.
7 days
for visible, lasting results²
90%
without recurrence³
45%
Reduces blemishes by -45% from 2 months⁴
1 Internal data in more than 90 countries, 2021. 2 Tolerance and efficacy study under dermatological control on 51 subjects, use of Cleanance Comedomed twice a day for 56 days. 3 International observational clinical study, 90% of patients without acne relapse at T6 months, (according to the definition of relapse in the protocol GEA≥3 requiring the introduction of an oral or local drug treatment), 48 subjects, 2 applications per day of Cleanance Comedomed alone for 6 months. 4 36 subjects with slight to moderate imperfections. Comparative clinical study (group treated twice/day N=18), control group (N=18) for 56 days.
